ALAMEDA, Calif. & TEL AVIV, Israel — BioTime, Inc. (NYSE MKT: BTX), a biotechnology company focused on the development and commercialization of cell-based therapies, announced today that the Tel Aviv Stock Exchange (TASE) has approved the new listing of BioTime’s common shares beginning on Tuesday, September 8, 2015 under the ticker symbol BTX. Based on […]
BELLSHILL, SCOTLAND – LINK (www.linktech.co.uk), the innovative developer and manufacturer of nucleic acid reagents, has announced the appointment of a new distributor in Switzerland – Chemie Brunschwig AG. This is LINK’s first formal partnership in Europe, and an important part of its strategy to strengthen Company representation in important market segments, thus increasing access to […]
ST. PAUL, Minn. –– 3M Food Safety announced today that its 3MTM Molecular Detection Assay 2 – Listeria monocytogenes has been approved by the AOAC® Performance Tested MethodsSM program (Certification 081501). The approval certifies that the next generation test kit is now equivalent or better than standard reference methods. Achieving AOAC PTM status required a […]
Melbourne, Australia: In a world where health care costs are escalating and demands on health care systems are becoming overwhelming, Trajan Scientific and Medical (Trajan) today announces the innovation of hemaPEN™, a prototype blood collection and storage device. Harnessing the benefits of Dried Blood Spot (DBS) sampling in an intuitive and safe portable format, hemaPEN […]
CAMBRIDGE, Mass. –– Gen9, Inc., a pioneer in the development of scalable technologies for synthesizing and assembling DNA, and iGEM, the International Genetically Engineered Machine Competition, today announced a collaboration to provide the synthetic biology community with the highest-quality, freely available DNA parts. The iGEM Foundation, which is dedicated to education and competition, advancement of […]
Oxford Gene Technology (OGT), the molecular genetics company, today announces a strategic realignment of its commercial operations to fuel further growth in its high value genomics products portfolio. As part of this realignment, OGT will transfer its next generation sequencing services business to Source BioScience (LSE: SBS). Financial details were not disclosed. Mike Evans, CEO […]
Redx is pleased to announce a cancer research collaboration with Horizon Discovery Group plc, (“Horizon”), the international life science group. The collaboration will focus on Redx’s existing pan-RAF inhibitor program, which is focused on colorectal cancer, the fourth most common cancer and the second most common cause of cancer death in the UK. Redx’s pan-RAF […]
ALAMEDA, Calif. – ESI BIO (esibio.com), the stem cell products division of BioTime, Inc., announced today the release of its most recent technology platform designed to give researchers new standardized in vitro assays with greater physiological relevance and accuracy. The VascuNet™ Pericyte Co-Culture Assay provides a stable, clinically relevant angiogenesis model not currently obtainable with […]
LA JOLLA, CA – SGI-DNA, a Synthetic Genomics, Inc. company announces the launch of the Gibson Assembly®Site-Directed Mutagenesis Kit which allows researchers to efficiently and accurately perform site-directed mutagenesis on DNA fragments. This kit is the third in SGI-DNA’s Gibson Assembly® portfolio, which empowers life science researchers to substantially increase their ability to build genes, […]
MOUNTAIN VIEW, Calif. — Hitachi Chemical Diagnostics, Inc. is pleased to announce the availability of the ExoComplete 96-Well Plate Kit and ExoComplete Tube Kit, an integrated, fast and easy system for exosome collection to mRNA purification. Both products are intended for research use only of molecular biology applications and are neither intended for the diagnosis, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
